UBS Upgrades Eastman Chemical to Buy, Raises Price Target to $128
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Joshua Spector has upgraded Eastman Chemical (NYSE:EMN) from Neutral to Buy and raised the price target from $106 to $128.
May 23, 2024 | 1:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst Joshua Spector has upgraded Eastman Chemical from Neutral to Buy and increased the price target from $106 to $128.
The upgrade from Neutral to Buy and the significant increase in the price target from $106 to $128 by a reputable analyst at UBS is likely to positively impact investor sentiment and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100